Tickerplace logo

Tickerplace

Mayne Pharma Group Limited logo

MYXMayne Pharma Group Limited

MYX Stock Price, Valuation & Chart | Mayne Pharma Group Limited

Compare
$2.520+0.03 (+1.20%)

At close · 16 Oct 2026, 05:10 am

Sector: HealthcareIndustry: Drug Manufacturers - GeneralWebsite
OverviewFinancialsDividendsRatios

MYX Historical price chart

MYX Key Stats

Market Capitalization206.37M
PE Ratio8.37
EPS0.3
Trading Volume103.57K
Today's High/Low2.62/2.5
Dividend Yield0.00
52 Week High/Low6.5/2.04
Shares Outstanding81.89M
MYX Financial Statement

MYX Analyst ratings

Buy

Strong buy
0
Buy
1
Hold
0
Sell
0
Strong sell
0

Based on 1 analyst giving stock ratings to MYX in the past 3 months.

MYX Analysis & performance metrics

MYX Company profile

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United…

MYX Management team

Management
Brenton Walter
Financial Controller
Lynn Sullivan
Executive Vice President & Leader of Women's Health
Daniel Moore
Executive Vice President of Specialty Products & Patient Solutions
Brant Schofield
Executive Vice President of Corporate Development
Erinn NathanielCTO
Director of Global Human Resources
Laura Loftus
Associate General Counsel & Company Secretary
Kimberly Parker J.D.
Executive Vice President & General Counsel
Shawn Patrick O'Brien B.ScCEO
Chief Executive Officer, MD & Director
Total 8 executives

MYX Frequently asked questions

What is Mayne Pharma Group Limited (MYX) Stock Price?

Current stock price of Mayne Pharma Group Limited (MYX) stock is $2.520. The stock price is +1.20% higher in the session. The intraday range can be seen from this page. Volume of Mayne Pharma Group Limited (MYX) stock is 103.57K.

Last updated at 16 Oct 2026, 05:10 am.

Why is the Mayne Pharma Group Limited (MYX) stock price going up or down today?

The stock price of Mayne Pharma Group Limited (MYX) can change with earnings, company news, and overall market sentiment. Mayne Pharma Group Limited operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Mayne Pharma Group Limited stock expensive at its current price?

Whether Mayne Pharma Group Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MYX on this page is 8.37. EPS on this page is 0.30. Compare those figures with peers and growth expectations before deciding if the current Mayne Pharma Group Limited price is justified.

How has the stock price of Mayne Pharma Group Limited (MYX) performed historically?

Historical performance for Mayne Pharma Group Limited (MYX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MYX reacted to past earnings and market events.

Should I buy Mayne Pharma Group Limited (MYX) stock, at this price?

Buying Mayne Pharma Group Limited (MYX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.